Literature DB >> 25385586

Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity.

Koen Wagner1, Mark J Kwakkenbos1, Yvonne B Claassen1, Kelly Maijoor1, Martino Böhne1, Koenraad F van der Sluijs2, Martin D Witte3, Diana J van Zoelen4, Lisette A Cornelissen4, Tim Beaumont1, Arjen Q Bakker1, Hidde L Ploegh3, Hergen Spits5.   

Abstract

Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodies. Many different formats of bispecific antibodies have meanwhile been developed. Most are genetic modifications of the antibody backbone to facilitate incorporation of two different variable domains into a single molecule. Here, we present a bispecific format where we have fused two full-sized IgG antibodies via their C termini using sortase transpeptidation and click chemistry to create a covalently linked IgG antibody heterodimer. By linking two potent anti-influenza A antibodies together, we have generated a full antibody dimer with bispecific activity that retains the activity and stability of the two fusion partners.

Keywords:  antibody engineering; immunotherapy; influenza

Mesh:

Substances:

Year:  2014        PMID: 25385586      PMCID: PMC4250106          DOI: 10.1073/pnas.1408605111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Stability engineering of scFvs for the development of bispecific and multivalent antibodies.

Authors:  Brian R Miller; Stephen J Demarest; Alexey Lugovskoy; Flora Huang; Xiufeng Wu; William B Snyder; Lisa J Croner; Norman Wang; Aldo Amatucci; Jennifer S Michaelson; Scott M Glaser
Journal:  Protein Eng Des Sel       Date:  2010-05-10       Impact factor: 1.650

2.  Universal epitopes of influenza virus hemagglutinins?

Authors:  Taia T Wang; Peter Palese
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

3.  Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design.

Authors:  Thomas Spreter Von Kreudenstein; Eric Escobar-Carbrera; Paula I Lario; Igor D'Angelo; Karine Brault; John Kelly; Yves Durocher; Jason Baardsnes; R Jeremy Woods; Michael Hongwei Xie; Pierre-Alain Girod; Michael D L Suits; Martin J Boulanger; David K Y Poon; Gordon Y K Ng; Surjit B Dixit
Journal:  MAbs       Date:  2013-07-08       Impact factor: 5.857

Review 4.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

5.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.

Authors:  J B Ridgway; L G Presta; P Carter
Journal:  Protein Eng       Date:  1996-07

6.  A common solution to group 2 influenza virus neutralization.

Authors:  Robert H E Friesen; Peter S Lee; Esther J M Stoop; Ryan M B Hoffman; Damian C Ekiert; Gira Bhabha; Wenli Yu; Jarek Juraszek; Wouter Koudstaal; Mandy Jongeneelen; Hans J W M Korse; Carla Ophorst; Els C M Brinkman-van der Linden; Mark Throsby; Mark J Kwakkenbos; Arjen Q Bakker; Tim Beaumont; Hergen Spits; Ted Kwaks; Ronald Vogels; Andrew B Ward; Jaap Goudsmit; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-11       Impact factor: 11.205

7.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

8.  A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.

Authors:  Donata De Marco; Nicola Clementi; Nicasio Mancini; Laura Solforosi; Guisella J Moreno; Xiangjie Sun; Terrence M Tumpey; Larisa V Gubareva; Vasiliy Mishin; Massimo Clementi; Roberto Burioni
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

9.  Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses.

Authors:  Yuval Avnir; Aimee S Tallarico; Quan Zhu; Andrew S Bennett; Gene Connelly; Jared Sheehan; Jianhua Sui; Amr Fahmy; Chiung-yu Huang; Greg Cadwell; Laurie A Bankston; Andrew T McGuire; Leonidas Stamatatos; Gerhard Wagner; Robert C Liddington; Wayne A Marasco
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

10.  Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.

Authors:  Mark Throsby; Edward van den Brink; Mandy Jongeneelen; Leo L M Poon; Philippe Alard; Lisette Cornelissen; Arjen Bakker; Freek Cox; Els van Deventer; Yi Guan; Jindrich Cinatl; Jan ter Meulen; Ignace Lasters; Rita Carsetti; Malik Peiris; John de Kruif; Jaap Goudsmit
Journal:  PLoS One       Date:  2008-12-16       Impact factor: 3.240

View more
  25 in total

1.  A Sortase A Programmable Phage Display Format for Improved Panning of Fab Antibody Libraries.

Authors:  Henry D Wilson; Xiuling Li; Haiyong Peng; Christoph Rader
Journal:  J Mol Biol       Date:  2018-09-11       Impact factor: 5.469

Review 2.  Bispecific antibodies for viral immunotherapy.

Authors:  Elisabeth K Nyakatura; Alexandra Y Soare; Jonathan R Lai
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

3.  Protein Labeling via a Specific Lysine-Isopeptide Bond Using the Pilin Polymerizing Sortase from Corynebacterium diphtheriae.

Authors:  Scott A McConnell; Brendan R Amer; John Muroski; Janine Fu; Chungyu Chang; Rachel R Ogorzalek Loo; Joseph A Loo; Jerzy Osipiuk; Hung Ton-That; Robert T Clubb
Journal:  J Am Chem Soc       Date:  2018-06-28       Impact factor: 15.419

4.  Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.

Authors:  B Cortjens; E Yasuda; X Yu; K Wagner; Y B Claassen; A Q Bakker; J B M van Woensel; T Beaumont
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

5.  Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo.

Authors:  G de Jong; L Bartels; M Kedde; E M E Verdegaal; M A Gillissen; S E Levie; M G Cercel; S E van Hal-van Veen; C Fatmawati; D van de Berg; E Yasuda; Y B Claassen; A Q Bakker; S H van der Burg; R Schotte; J Villaudy; H Spits; M D Hazenberg; P M van Helden; K Wagner
Journal:  Cancer Immunol Immunother       Date:  2020-11-23       Impact factor: 6.968

6.  Dynamic control of hydrogel crosslinking via sortase-mediated reversible transpeptidation.

Authors:  Matthew R Arkenberg; Dustin M Moore; Chien-Chi Lin
Journal:  Acta Biomater       Date:  2018-11-08       Impact factor: 8.947

7.  Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice.

Authors:  Marijn A Gillissen; Greta de Jong; Martijn Kedde; Etsuko Yasuda; Sophie E Levie; Gemma Moiset; Paul J Hensbergen; Arjen Q Bakker; Koen Wagner; Jullien Villaudy; Pauline M van Helden; Hergen Spits; Mette D Hazenberg
Journal:  Blood Adv       Date:  2017-08-18

Review 8.  Stable long-term cultures of self-renewing B cells and their applications.

Authors:  Mark J Kwakkenbos; Pauline M van Helden; Tim Beaumont; Hergen Spits
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

Review 9.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

Authors:  William R Strohl; Michael Naso
Journal:  Antibodies (Basel)       Date:  2019-07-03

10.  A clickable glutamine (CliQ) derivative for the traceless reversible modification of peptides and proteins.

Authors:  Samuel D Whedon; Marissa K Parker; Elizabeth L Tyson; Tobias Ritterhoff; Patrick M M Shelton; Champak Chatterjee
Journal:  Chem Commun (Camb)       Date:  2019-02-12       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.